Abstract:OBJECTIVE:To explore the appearances of digital subtraction angiography (DSA) and therapeutic efficacy of interventional therapy of hepatic carcinoma accompanied with arteriovenous shunting (AVS).METHODS:To retrospectively analyze clinical material of 97 patients with hepatocellular carcinoma with hepatic artery-portal vein shunting(HA-PVS), of whom, 16 had upper gastrointestinal hemorrhage, 51 had middle to large amounts of ascites, and 53 had varices of esophagus and fundus gastricus. All the patients were treated with transcatheter arterial chemoembolization (TACE) or transcatheter arterial infusion chemotherapy (TAI). Shunts were embolized by lipidol in 40 patients, by lipidol and sponjgia gelatinosa particle in 34 patients, and by coil in 6 patients. The remaining 17 were treated only with TAI.RESULTS:Twelve (12.4%) cases had hepatic arteryjhepatic vein shunting (HA-HVS)ìwhile 32 (33%)cases had portal vein tumor thrombosis (PVTT). In 70(72.2%) patients, all shunts were completely closed successfully, in 15(15.5%) patients, the shunts were partly closed, and in 12(12.3%)patients, the shunts were not closed. In 12 patients, the shunts reopened in later therapy, their blood flow was smaller than before and they were closed after second embolization. In 17 patients, new shunts emerged. After TACE therapy ìthe tumors were smaller in 57(58.7%)ìbigger in 24 (24.7%)ìand 16(16.5%) were the same in size before and after TACE. Ascites disappeared in 29 patients, decreased in 18 patients and had no change in 4 patients. Five patients who had upper gastrointestinal hemorrhage prejoperation had new hemorrhage. Of the 47 patients who had diarrhea, 23 improved. In 67 alpha fetoprotein (AFP) positive patients, degree of AFP in 53 patients decreased. Eighty-one patients died and their middle survival period was 12.9 months. No serious damage to hepatic function due to the treatment was observed in most patients.CONCLUSION:Primary hepatic carcinoma with AVS increases difficulty of interventional therapyìbut as long as we take active and proper treating measureìwe could acquire satisfactory curative effect without serious syndrome. DSA can demonstrate the type, the site and the degree of AVS completely and directly, thus having important value in treating primary hepatic carcinoma and improving prognosis.

Interventional therapy for primary liver cancer complicated with hepatic arteriovenous fistula

Evaluation of the Efficacy for Alternated Treatment on Primary Liver Cancer by Interventional Therapy in Combination with Fractionated Stereotactic Conformal Radiotherapy

Prolong Overall Survival Rate for Patients with Liver Cancer Receiving Double Interventional Therapy

Therapeutic Evaluation of Arterio-Portal Fistula-Related Gastroesophageal Variceal Bleeding

Imaging characteristics and intervention therapy for hepatic artery-portal vein shunts in patients with primary liver carcinoma

The Role of Interventional Treatment on Hepatocellular Carcinoma Combined with Portal Vein Tumor Thrombosis

Interventiona1 diagnosis and treatment of hepatic artery complications after liver transplantation

Vascular and Biliary Complications after Liver Transplantation: Interventional Approaches

Digital Subtraction Angiography Manifestation and Interventional Therapy of Arteriovenous Shunting in Primary Hepatocellular Carcinoma of Advanced Stage

Successful treatment of refractory ascites in a patient with liver cirrhosis combined with hepatic artery-portal vein malformation: A case report

[Interventional Therapy of Hepatic Artery-Portal Vein Fistula with Gelatin Sponge and Lipiodol].

[Vascular Complications after Orthotopic Liver Transplantation].

Primary Investigation of the Intervention Therapies to Arteriovenous Fistula Stenosis

Editorial: Interventional Therapy of Hepatocellular Carcinoma

Application of interventional catheterization procedure in arteriovenous fistula dysfunction

Exploration of interventional therapy strategy for portal vein occlusion: a case series study

Primary hepatocellular carcinoma associated with portal vein tumor thrombus: report of one case with survival over 5 years and review of literature

Diagnosis and treatment of hepatic arterioportal fistula

Current Status of Transcatheter Arterial Chemoembolization Combined with Radiofrequency Ablation in Treatment of Primary Liver Cancer

Minimally Invasive Treatment of Large HCC-Reevaluation Hepatic Artery Ligation and Intubation to Large HCC

Combined Iodine-125 Seed Strand, Transarterial Chemoembolizaiton, Lenvatinib and Anti-PD-1 Antibodies Therapy for Unresectable Hepatocellular Carcinoma and Vp4 Portal Vein Tumor Thrombus: A Real-world Study